Generically modified plants (GMP) are massively used on the American continent in Australia and in China, since they represent an unquestionable potential for progress. New attributes are therefore devoted to the human and animal diet, to the facilitating of culture management, to the reducing of the chemical fertilizer and pesticide usage, and to the conquest of new cultural spaces. Considering itself to be flawed by a too hasty plunge into the market, concomitant with sagging evaluations of other innovations, Europe is confronted by a strong societal debate which blocks GMP cultures and orientates the research towards an evaluation of the environmental and public health risks and an evaluation of their economical and sociological impacts. The authors encourage this societal debate in order to arbitrate the presence of transgenes in conventional productions and products, to define the accepted rules of responsibility, to decide what is not acceptable, and to involve the more upstream actors and operators of the innovation process, all that keeping in mind the agronomical, ecological and economical repercussions of their decisions.